First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis.
Sci Rep
; 11(1): 19827, 2021 10 06.
Article
in En
| MEDLINE
| ID: mdl-34615968
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Signal Transduction
/
Phosphate-Binding Proteins
/
Immunosuppressive Agents
/
Membrane Proteins
/
Anti-Inflammatory Agents
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Sci Rep
Year:
2021
Type:
Article
Affiliation country:
United States